Growth Metrics

Carlsmed (CARL) EBT Margin (2024 - 2026)

Carlsmed posted quarterly EBT Margin of 53.96% for Q1 2026, up 194.0% year-on-year from 18.35% in Q1 2025, and up 5.07% on a QoQ basis from 56.84% in Q4 2025.

Carlsmed (CARL) has 3 years of EBT Margin data on file, last reported at 53.96% in Q1 2026.

  • For the quarter ending Q1 2026, EBT Margin rose 194.0% year-over-year to 53.96%; the trailing twelve-month figure through Mar 2026 stood at 57.24% (up 1826.0% YoY), and the FY2025 full-year result was 58.02%, up 3075.0% from the prior year.
  • EBT Margin for Q1 2026 stood at 53.96%, up from 56.84% in the prior quarter.
  • Across five years, EBT Margin topped out at 49.59% in Q4 2024 and bottomed at 118.13% in Q3 2024.
  • The 3-year median for EBT Margin is 56.37% (2025), against an average of 69.42%.
  • Peak annual rise in EBT Margin reached 5342 bps in 2025, while the deepest fall reached 726 bps in 2025.
  • A 3-year view of EBT Margin shows it stood at 49.59% in 2024, then retreated by 15 bps to 56.84% in 2025, then climbed by 5 bps to 53.96% in 2026.
  • The last three EBT Margin figures came in at 53.96% (Q1 2026), 56.84% (Q4 2025), and 64.72% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Veeva Systems 30.85 Bn 24.28 Bn 622.47 Mn 37.99%
2 BrightSpring Health Services 12.29 Bn 11.41 Bn 482.22 Mn 2.29%
3 Healthequity 7.80 Bn 7.48 Bn 256.31 Mn 26.06%
4 Hinge Health 4.82 Bn 4.51 Bn 154.23 Mn 19.72%
5 Doximity 4.21 Bn 3.46 Bn 125.97 Mn 22.10%
6 Waystar Holding 4.18 Bn 4.03 Bn 268.04 Mn 19.06%
7 10x Genomics 3.78 Bn 3.24 Bn 106.18 Mn -8.52%
8 Privia Health 2.65 Bn 2.28 Bn 595.71 Mn 1.54%
9 Omnicell 1.95 Bn 1.78 Bn 140.36 Mn 5.46%
10 Carlsmed 298.68 Mn 201.48 Mn 12.43 Mn -53.96%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -53.96%
Dec 31, 2025 -56.84%
Sep 30, 2025 -64.72%
Jun 30, 2025 -54.03%
Mar 31, 2025 -55.90%
Dec 31, 2024 -49.59%
Sep 30, 2024 -118.13%
Jun 30, 2024 -102.22%